Cellular pharmacology of mitoxantrone in p-glycoprotein-positive and -negative human myeloid leukemic cell lines

被引:27
作者
Consoli, U [1 ]
Van, NT [1 ]
Neamati, N [1 ]
Mahadevia, R [1 ]
Beran, M [1 ]
Zhao, S [1 ]
Andreeff, M [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Hematol, Sect Expt Hematol, Houston, TX USA
关键词
mitoxantrone; p-glycoprotein; multidrug resistance;
D O I
10.1038/sj.leu.2400511
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous reports suggest that resistance to mitoxantrone in different turner cell lines is unrelated to the overexpression of p-glycoprotein, In order to determine the role of p-glycoprotein in the cellular pharmacology of mitoxantrone flow cytometry and confocal microscopy were used to study two human myeloid leukemia cell lines selected for resistance to mitoxantrone (HL-60MX2) and doxorubicin (HL-60DOX). To optimize the detection of intracellular mitoxantrone, we determined the maximum excitation (607 nm) and emission (684 nm) wavelength by fluorescence spectroscopy. The modified flow cytometric conditions using 568.2 nm laser emission for excitation and a 620 nm long pass filter for fluorescence collection resulted in a 1-log increase in sensitivity, compared with standard 488-nm laser excitation. Uptake and retention of mitoxantrone in the presence of verapamil, a calcium channel blocker known to inhibit p-glycoprotein, were analyzed. Our results showed no change in uptake and retention of the drug in p-glycoprotein-negative mitoxantrone-resistant HL-60MX2 cells and in its sensitive parental line, HL-60s. In contrast, 3.1- and 2.4-fold increases were found in uptake and retention of mitoxantrone in p-glycoprotein-positive cells (HL-60DOX) incubated with verapamil. Confocal microscopy of intracellular drug distribution demonstrated reduced nuclear uptake, which could be reversed by verapamil, in HL-60DOX. a characteristic punctate pattern was observed for the intracytoplasmic drug distribution in HL-60DOX and HL-60MX2 cells and was partially modified by the presence of verapamil in HL-60DOX cells. Verapamil increased cytotoxicity of mitoxantrone two-fold in HL-60DOX cells, 1.4-fold in HL-60MX2, and had no effect in HL-60s. Our study demonstrates that the cellular pharmacology of mitoxantrone is affected by p-glycoprotein and can be reversed at least in part by verapamil. Other mechanisms of resistance however, seem to play a determinant role in the modulation of mitoxantrone cytotoxicity.
引用
收藏
页码:2066 / 2074
页数:9
相关论文
共 40 条
[1]  
ALBERTS DS, 1985, INVEST NEW DRUG, V3, P101
[2]  
ARLIN Z, 1990, LEUKEMIA, V4, P177
[3]   TREATMENT OF BLASTIC TRANSFORMATION OF CHRONIC MYELOGENOUS LEUKEMIA WITH MITOXANTRONE [J].
ARLIN, ZA ;
BERMAN, E ;
JHANWAR, S ;
GAMS, R ;
SCHOCH, I ;
DUKART, G .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 17 (02) :189-190
[4]   MITOXANTRONE - AN ACTIVE AGENT IN REFRACTORY NON-HODGKINS LYMPHOMAS [J].
BAJETTA, E ;
BUZZONI, R ;
VALAGUSSA, P ;
BONADONNA, G .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (02) :100-103
[5]  
BERMAN E, 1991, BLOOD, V77, P818
[6]  
BERMAN E, 1992, BLOOD, V79, P3267
[7]  
BEZWODA WR, 1990, CANCER, V66, P418, DOI 10.1002/1097-0142(19900801)66:3<418::AID-CNCR2820660303>3.0.CO
[8]  
2-K
[9]   DNA DAMAGE AND CYTOTOXICITY OF MITOXANTRONE AND DOXORUBICIN IN DOXORUBICIN-SENSITIVE AND DOXORUBICIN-RESISTANT HUMAN COLON-CARCINOMA CELLS [J].
CAPOLONGO, L ;
BELVEDERE, G ;
DINCALCI, M .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (06) :430-434
[10]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159